ARCHIVES

Gleevec Maintenance Therapy Showed Significant Benefits At Three Years in Phase III Trial

This article is from The Cancer Letter archive.

Vol. 35 No. 4 | April 27, 2012

Download PDF Visit The Full Archive

Related Articles

Study Finds No Link Between Pill And Breast Cancer Risk

July 26, 2002

Administration To Hold ASSIST Funding To ’92 Level; ACS Says Result Is Percent Cut

March 20, 1992

Ending Breast Cancer by 2020? NBCC President Fran Visco Discusses the Goal

January 25, 2013

Budesonide Not Beneficial For Diarrhea In Melanoma

August 28, 2009

National Lung Cancer Partnership Announces Annual Grant Competition

August 9, 2013

Cytyc Buys Pro-Duct Health, Ductal Lavage Device Maker. TAP To Pay $875 Million To Settle Federal Civil Suit.

October 26, 2001